Filing Details
- Accession Number:
- 0001140361-13-046216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-13 19:35:15
- Reporting Period:
- 2013-12-11
- Filing Date:
- 2013-12-13
- Accepted Time:
- 2013-12-13 19:35:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 69499 | Mylan Inc. | MYL | Pharmaceutical Preparations (2834) | 251211621 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534275 | Anthony Mauro | 1500 Corporate Drive Canonsburg PA 15317 | President, North America | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-11 | 13,089 | $21.13 | 31,507 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-11 | 13,089 | $42.01 | 18,418 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-12-11 | 8,698 | $22.66 | 27,116 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-11 | 8,698 | $41.98 | 18,418 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option Right to Buy | Disposition | 2013-12-11 | 13,089 | $0.00 | 13,089 | $21.13 |
| Common Stock | Stock Option Right to Buy | Disposition | 2013-12-11 | 8,698 | $0.00 | 8,698 | $22.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-03-03 | No | 4 | M | Direct | |
| 4,865 | 2021-03-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,574 | Indirect | By 401(k) Plan |
Footnotes
- Represents the weighted average price of the reporting person's disposition of 13,089 shares in transactions ranging from $41.82 to $42.48.
- The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 3 to this Form 4.
- Represents the weighted average price of the reporting person's disposition of 8,698 shares in transactions ranging from $41.69 to $42.46.
- This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 22, 2013.
- The options vested in three equal installments on March 3, 2011, 2012, and 2013.
- Two-thirds of the options vested in equal installments on March 2, 2012 and 2013. The remainder of the options will vest on March 2, 2014.
Billionaire Hedge Funds
